Doctor profile · Federal record

Dr. Venu Bathini, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Framingham, MA

  • NPI 1578658563
  • Accepts Medicare
  • 32 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
571 Union Ave Ste 202
Framingham, MA 017025829
(508) 665-6261
fax (508) 665-4175
Mailing address
171 Main St Ste 203B
Ashland, MA 017211187

Credentials & registration

NPPES · NUCC
NPI registered
October 2006 — 20 yrs on file
Profile last updated
October 26, 2023
Year of graduation
1994 — 32 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Massachusetts #208195
Medicaid
MA #110033110A

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1578658563. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
72,526
Distinct HCPCS
10
Medicare allowed
$378,133
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 38,250 23 $1
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 24,990 26 $1
J0897 Injection, denosumab, 1 mg 5,940 53 $23
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 546 171 $8
36415 Insertion of needle into vein for collection of blood sample 415 179 $8
99214 Established patient office or other outpatient visit, 30-39 minutes 412 185 $139
96375 Injection of additional new drug or substance into vein 308 38 $18
J7050 Infusion, normal saline solution, 250 cc 278 63 $1
99213 Established patient office or other outpatient visit, 20-29 minutes 238 153 $99
96372 Injection of drug or substance under skin or into muscle 226 74 $16

In context: peer comparison

Among 2 peers in this city , average services per provider: 3,778. This provider delivers 19× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$727
Transactions
20
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
PROGENICS PHARMACEUTICALS, INC. 1 $125.00
Novartis Pharmaceuticals Corporation 2 $62.79
PFIZER INC. 2 $62.29
E.R. Squibb & Sons, L.L.C. 2 $58.58
Celgene Corporation 2 $56.55
GlaxoSmithKline, LLC. 2 $46.75
Janssen Biotech, Inc. 1 $37.03
BeiGene USA, Inc. 1 $34.07
Merck Sharp & Dohme LLC 1 $30.86
ARRAY BIOPHARMA INC 1 $28.71
Novocure Inc. 1 $28.29
AstraZeneca Pharmaceuticals LP 1 $27.48
Karyopharm Therapeutics Inc. 1 $24.68
Tempus AI, Inc 1 $23.44
ADC Therapeutics America, Inc. 1 $23.42

By nature of payment

Food and Beverage
$688
Education
$39

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
303
Patients
43
Total drug cost
$432,178
Drug Type Claims Patients Total cost
Eliquis (Apixaban) Brand 68 19 $83,750
Hydroxyurea Generic 34 11 $1,714
Ondansetron Odt (Ondansetron) Brand 25 13 $530
Xarelto (Rivaroxaban) Brand 25 0 $36,838
Letrozole Generic 20 0 $1,024
Oxycodone Hcl Generic 17 0 $101
Dexamethasone Generic 16 0 $235
Acetaminophen-Codeine (Acetaminophen With Codeine) Brand 14 0 $156
Reblozyl (Luspatercept-Aamt) Brand 14 0 $164,137
Meloxicam Generic 12 0 $34

Frequently asked questions

Auto-generated from federal data
What is Dr. Venu Bathini's medical specialty?
Dr. Venu Bathini practices Hematology & Oncology Physician in Framingham, MA.
Where does Dr. Venu Bathini practice?
Dr. Venu Bathini practices at 571 Union Ave Ste 202, Framingham, MA 017025829. Office phone: 5086656261.
What is Dr. Venu Bathini's NPI?
Dr. Venu Bathini's National Provider Identifier (NPI) is 1578658563, issued by NPPES.
Does Dr. Venu Bathini accept Medicare assignment?
Yes. Dr. Venu Bathini accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Venu Bathini commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.